YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(9)
- Austria(1)
- Belgium(4)
- Canada(60)
- China(26)
- Denmark(2)
- Estonia(2)
- Finland(1)
- France(13)
- Germany(44)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(79)
- Indonesia(1)
- Ireland(2)
- Israel(2)
- Italia (6)
- Japan(2)
- Latvia(1)
- Lithuania(1)
- Mexico(2)
- New Zealand(2)
- Peru(1)
- Poland(2)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(17)
- Sweden(3)
- Switzerland(23)
- Taiwan(4)
- The Czech Republic(2)
- The Netherlands(6)
- Turkey(2)
- Ukraine(2)
- United Kingdom(57)
- United States(704)
- Vietnam(1)
Contract Service Directory
Seqens Innovative & Generic Pharmaceuticals (I&GP) North America
Company Headquarters
9 Opportunity Way
Newburyport, MA 01950
United States
Contract Service Directory
- Analytical Laboratory Services
- cGMP Synthesis
- CMC (Chemistry, Manfacturing & Controls)
- Contract Development and Manufacturing Organization (CDMO)
- Manufacturing, API
- Manufacturing, Custom
- Manufacturing, Generics
- Micronization
- Organic Synthesis
- Process Development/Scale-Up Services
- Process R&D
- Process Validation Studies
- Quality Control Testing
- R&D Services
- Stability, ICH
Related Content
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Further Invests in Drug Product Manufacturing Capabilities
New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.09.22.21
-
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
Ink multi-year development and manufacturing agreement for mRNA COVID-19 vaccine candidate, PTX-COVID19-B.09.14.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
FUJIFILM Diosynth Biotechnologies, NeuExcell Enter Gene Therapy Mfg. Pact
Aims to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke.09.13.21
-
APIs | Clinical Trial Materials
Outsourcing the Manufacture of Clinical Trial APIs
What to consider when deciding to partner with a CDMO for manufacturing.Josh Hoerner, General Manager, Purisys 09.09.21
-
Drug Development
Partnering with a CDMO for Orphan Drug Development
Challenges and considerations for advancing rare disease drugs to market.Susan Billings, Vice President & Global Head of Business Development, Curia (formerly known as AMRI) 09.09.21
-
Global Outsourcing Trends
Lonza’s Jan Vertommen talks about building global manufacturing and development networks to advance innovative, life-saving therapies.Tim Wright, Editor, Contract Pharma 09.09.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Recro and BioCorRx Expand Development and Manufacturing Relationship
Will support BICX104, an implantable naltrexone pellet for the treatment of opioid use disorder.09.08.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Secarna, Evotec Expand Strategic Antisense Discovery Pact
To discover, research and develop programs leveraging Secarna’s antisense oligonucleotide expertise with Evotec’s discovery and development capabilities.09.02.21
-
Biologics, Proteins, Vaccines | Breaking News
Avantor Commences Multi-Year Investment in Global Hydration Capabilities
Completes a major expansion of its facility in Gliwice, Poland, and begins a multi-stage expansion of its facility in Aurora, Ohio.08.31.21
-
Breaking News | Industry News | Promotions & Moves
Forge Biologics Expands Leadership Team
Announces two key hires in process development and medical affairs.08.30.21
-
Analytical Services | Breaking News | Industry News | Laboratory Testing
Recipharm Strengthens Analytical Services Capabilities
CDMO launches new laboratory at its facility in Bengaluru, India to expand analytical services offering.08.26.21
-
Breaking News | Collaborations & Alliances
Lilly, Lycia Therapeutics Enter Multi-Year R&D Alliance
Will leverage Lycia's LYTAC protein degradation technology to discover, develop and commercialize targeted therapeutics in immunology and pain.08.25.21
-
Breaking News | Facilities | Industry News
Xellia’s Cleveland Manufacturing Facility is Commercially Operational
Site producing key anti-infective drug products for U.S. hospitals and patients.08.20.21
-
APIs | Breaking News | Facilities | Industry News
Curia to Expand U.S. Commercial Manufacturing Capability
Roughly $35 million will be invested to expand manufacturing and product-handling solutions for complex small molecules.08.19.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Syngene Expands Biopharma Manufacturing Capacity
Sets up a state-of-the-art microbial facility; expands mammalian facility.08.17.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Lykan and Vineti Form Cell Therapy Agreement
Partnership will streamline process development and manufacturing to deliver therapies to patients in need.08.13.21
-
Breaking News | Facilities | Industry News | Packaging & Tracking
Comar Cuts Ribbon on New West Coast Facility
The 230,000 square foot facility houses injection molding, injection blow molding and injection stretch blow molding cells.08.13.21
-
Bachem Capabilities to Address the New FDA Guideline for Synthetic Peptides
Scientific and regulatory challenges remain a big hurdle on the way to successful approval of generic drugs falling under this guideline.
-
Biologics, Proteins, Vaccines | Breaking News
Evotec Opens cGMP Manufacturing Facility in Redmond, WA
Expands capabilities into commercial biologics manufacturing and adds late stage clinical development and commercial supply for drug substance.08.11.21
-
Analytical Services | Biologics, Proteins, Vaccines | Cold Chain Management | GMPs/GCPs | Scale-up/Technology Transfer | Serialization | Solid Dosage/Semi-solids | Vials
CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers
Aphena is a service provider in the pharmaceutical, OTC, medical device, biologics and personal care industries.
-
APIs
Generic APIs Portfolio
With almost 50 years of expertise in peptide and small molecule synthesis, Bachem has an outstanding track record in large-scale manufacturing.
-
Breaking News | Industry News
KYOWA, Bora Pharmaceuticals Enter Mfg. Pact
Upon approval in Japan, Bora will be the commercial manufacturing site for the generic product production.08.10.21
-
The Real Cost of Bringing Manufacturing Home
Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.08.04.21
-
Breaking News | Facilities | Industry News
Celanese Opens Pharma Drug Delivery Feasibility Lab
State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.07.29.21
-
Breaking News | cGMP Manufacture | Industry News
WuXi Biologics Receives Manufacturing License from German Health Authorities
The inspections comprised areas of cGMP manufacturing required for receiving the permit, as well as commercial production approval.07.26.21
-
Bio News | Breaking News | Industry News
Catalent Biologics Launches GPEx Lightning Cell Line Expression Technology
Designed to shorten drug substance development timelines by up to three months.07.22.21
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Marvel Biotechnology Begins cGMP Manufacturing of Lead Candidate
Enters manufacturing agreement with Ausun Pharma for lead asset MB-204.07.22.21
-
Breaking News | Promotions & Moves
TCR2 Therapeutics Appoints Chief Technical Officer
Peter Olagunju to oversee process development, manufacturing, quality control and technical operations for the company’s TRuC-T cell programs.07.21.21
-
Biologics, Proteins, Vaccines | Drug Development | Reader Showcase
Thermo Fisher Scientific Launches Heracell Vios CR CO2 Incubator
First-in-market CO2 incubator combines optimal cell growth capabilities with certified cleanroom compatibility.07.21.21
-
Breaking News | Facilities | Industry News
Evergreen Expands Alpha Radiopharmaceutical Production Capabilities
A GMP state-of-the-art alpha emitter production center will be integrated into Evergreen’s existing facility.07.20.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
ImmVira Launches Pilot-scale Production Line
To expedite the advancement of next-generation oncolytic virus clinical trials.07.20.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Curtana and Catalent Enter Brain Cancer Drug Partnership
Sign development and manufacturing agreement for brain cancer drug CT-179.07.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.07.16.21
-
Breaking News
Thermo Fisher Scientific Opens New Plasmid DNA Manufacturing Facility
Enables the company to meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.07.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Curia to Acquire US-based LakePharma
Expanding end-to-end R&D capabilities and scale for biologics.07.14.21
-
Breaking News | Collaborations & Alliances
Bicycle Therapeutics, Ionic Pharma Enter License & Collaboration Agreement
Will work together to develop targeted oligonucleotide therapeutics leveraging tissue-targeting TfR1 Bicycle technology.07.13.21
-
Breaking News | cGMP Manufacture | Drug Development | Formulation Development | Industry News
Recro Pharma Inks Development and Mfg. Pact
To support a client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound.07.13.21
-
Analytical Services | Breaking News | Industry News | Laboratory Testing
LGM Pharma Launches Analytical Services for Drug Developers and Manufacturers
Analytical testing and stability services covers both drug substance and drug product.07.08.21
-
Breaking News | cGMP Manufacture
Thermo Fisher Scientific Expands Gene Therapy Portfolio
Adds new set of solutions to support more efficient adeno-associated viral manufacturing.07.07.21
-
Facilities | Laboratory Testing | Logistics
A Guide to Outsourced Stability Storage
Watch the on-demand webinar presented by Maureen Gilbert, Site General Manager at Source BioScience.
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
Novasep, Exelixis Ink ADC Manufacturing Agreement
Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.07.06.21
-
Analytical Services | Breaking News | cGMP Manufacture | Collaborations & Alliances | Formulation Development
Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program
Will leverage integrated services from Selexis and KBI as part of Immatics’ development of TCR Bispecifics, designed to detect, target and attack tumor cells.06.30.21
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
WuXi STA Chooses Middletown Delaware for New Pharma Manufacturing Campus
The CDMO is bringing about 500 jobs to Middletown, with site expected to open in 2024.06.29.21
-
Analytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Drug Development
Host Cell Impurities, Bioassays, Micro-Flow Imaging
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.
-
Formulation Development
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.06.25.21
-
APIs | Breaking News | Facilities | Industry News
Novasep Upgrades API Manufacturing Facility
A $7.3 million investment will be made over 3 years to modernize the Mourenx site.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Senti Bio Invests in Cell Therapy Manufacturing Facility
92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline.06.23.21
-
Lonza and ValenzaBio Enter Clinical Manufacturing Agreement
Lonza will provide drug substance and drug product manufacturing under accelerated timelines for monoclonal antibody treatment at Guangzhou facility.06.21.21
-
APIs | Supply Chain
Maintaining Critical Drug Supply During the Pandemic
Vin Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.Tim Wright, Editor, Contract Pharma 06.17.21
-
Breaking News | Collaborations & Alliances | Industry News
KBI Biopharma, AM-Pharma Enter Manufacturing Agreement
Partnership supports future commercial manufacturing for AM-Pharma’s potential kidney disease treatment.06.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.06.15.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
Third milestone payment related to the development of Oral KORSUVA.06.11.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Revolo and Northway Biotech Enter Manufacturing Partnership
To manufacture novel binding immunoglobulin protein, ‘1805, to support phase 2 trials in rheumatoid arthritis and uveitis.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Vibalogics Expands Manufacturing Capacity
Invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors.06.11.21
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Inspections | Process Validation | Risk Management
Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates
Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.
-
Facilities | Solid Dosage/Creams/Ointments
Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm
Newly expanded labs bolster testing, formulation development, and manufacturing services.Tim Wright, Editor, Contract Pharma 06.03.21
-
Breaking News | Facilities | Industry News | Inspections
CPL Completes Successful Virtual Health Canada Audit
The CDMO created a virtual tour of its facilities in response to the pandemic.Tim Wright, Editor, Contract Pharma 06.03.21
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The modernization of advanced therapy manufacturing.Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
Samsung Biologics Expands Vaccine Manufacturing Capabilities
To add mRNA vaccine drug substance manufacturing suite to expand portfolio of services.Tim Wright, Editor, Contract Pharma 06.01.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The Modernization of Advanced Therapy ManufacturingDr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21
-
Breaking News | Collaborations & Alliances | Industry News
Hovione and iBET Form Strategic Collaboration
Will combine knowledge from both partners to create innovation in new therapeutic fields.Tim Wright, Editor, Contract Pharma 05.27.21
-
Bio News | Breaking News | Industry News
August Bioservices Expands U.S. Biopharma Manufacturing Capabilities
$23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of sterile injectables.Tim Wright, Editor, Contract Pharma 05.27.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cambrex Adds Kilogram-Scale Mfg. Capabilities at Estonia
Building work and installation of the new reactor and supporting equipment is now complete, and preparation for GMP qualification is underway.Kristin Brooks 05.26.21
-
Breaking News | Promotions & Moves
Sterling Pharma Appoints Stewart Mitchell as New Site Head
Will lead new antibody-drug conjugate (ADC) facility in Deeside, UK.Kristin Brooks 05.24.21
-
Breaking News | Facilities | Industry News | Lyophilization
Argonaut Expands Lyophilization Facility
Enhances manufacturing capabilities with major investment in lyophilization facility expansion.Tim Wright, Editor, Contract Pharma 05.21.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
Thermo Fisher, UCSF to Open Cell Therapy cGMP Mfg. Center
Thermo Fisher will build and operate a 44,000-sq.-ft. cell therapy development, manufacturing and collaboration center on UCSF's Mission Bay campus.Kristin Brooks 05.20.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
WuXi Biologics, WuXi STA Establish WuXi XDC JV
To provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs).Kristin Brooks 05.14.21
-
Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Novasep Expands HPAPI Manufacturing Capacity
Responds to increasing customer demand for manufacturing services for antibody drug conjugates.Tim Wright, Editor, Contract Pharma 05.13.21
-
Bio News | Breaking News | Facilities
NJ Bio Moves Headquarters to Princeton, New Jersey
The 35,000-square-foot site was formerly occupied by Bristol Myers Squibb.Tim Wright, Editor, Contract Pharma 05.11.21
-
Analytical Services | Breaking News | Facilities | Industry News | Laboratory Testing
Cambrex Expands Analytical Services Capabilities
Adds 1,800 square feet of lab space at Longmont, CO facility.Tim Wright, Editor, Contract Pharma 05.11.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
OncoTEX, Sterling Pharma Sign Clinical Mfg. Pact
Sterling will produce clinical material for OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX, for use in clinical trials.Kristin Brooks 05.10.21
-
Breaking News | Facilities | Fill/Finish | Industry News | Parenterals | Vials
Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics
New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.Tim Wright, Editor, Contract Pharma 05.07.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.Charles Sternberg, Assistant Editor 05.07.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent Acquires Commercial-Scale Plasmid DNA Mfg. Facility
Promethera’s Hepatic Cell Therapy Support SA include's 32,400 sq.-ft. facility in Gosselies, Belgium.Kristin Brooks, Contract Pharma 05.06.21
-
Breaking News | Facilities | Fill/Finish | Industry News
Grand River Aseptic Manufacturing Earns Facility of the Year Award
Receives special recognition for operational agility during the pandemic.Charles Sternberg, Assistant Editor 04.29.21
-
Analytical Services | Bioanalytical Services | Breaking News | CRO News | Facilities | Industry News
PPD to Expand GMP Lab in Ireland
Adding cell and gene therapy capabilities to support growing customer need.Tim Wright, Editor, Contract Pharma 04.29.21
-
Breaking News | Facilities | Industry News
Lonza to Build Small Molecule Manufacturing Complex in Visp
Will invest $220 million to construct the complex that will include a manufacturing line for antibody-drug conjugate payload molecules.Tim Wright, Editor, Contract Pharma 04.23.21
-
Breaking News | Facilities | Industry News | Inspections
Bora Pharmaceuticals Completes Health Canada Inspection
Mississauga site is the company’s first manufacturing facility in North America and is its HQ in the region.Tim Wright, Editor, Contract Pharma 04.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture
Evotec to Build Second Biologics Mfg. Facility in Toulouse
Evotec's first commercial biomanufacturing facility in Europe is anticipated to deliver much needed capacity for biotherapeutic development and manufacturing.Kristin Brooks 04.20.21
-
Breaking News | Industry News
Revolo Biotherapeutics, CordenPharma Enter Master Service Agreement
Will scale up and manufacture ‘1104 for the treatment of eosinophilic esophagitis and allergic disease.Charles Sternberg, Assistant Editor 04.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Resilience Acquires Ology Bioservices
Continues expansion with acquisition of biologics manufacturing company.Tim Wright, Editor, Contract Pharma 04.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Abenza Chooses North Carolina for New Biologics Manufacturing Site
GMP manufacturing will commence in mid-2022.Charles Sternberg, Assistant Editor 04.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent Biologics Completes Madison Expansion
More than doubles overall CGMP-scale capacity increasing the number of manufacturing suites at the site to five.Kristin Brooks 04.13.21
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Bora Pharmaceuticals Adds Roller Compaction Capabilities
Installed at Zhunan, Taiwan facility known for manufacturing complex oral solid dose formulations.Tim Wright, Editor, Contract Pharma 04.09.21
-
Analytical Services | Bioanalytical Services | Breaking News | Industry News
Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.Kristin Brooks 04.08.21
-
Bio News | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Sterling Pharma Solutions Acquires ADC Biotechnology
Will establish a center of excellence for bioconjugation and ADC development and manufacturing services.Tim Wright, Editor, Contract Pharma 04.07.21
-
Bioanalytical Services | Breaking News | CRO News | Industry News
Charles River Acquires Retrogenix
Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.Tim Wright, Editor, Contract Pharma 04.05.21
-
Breaking News | Industry News
Lonza Completes Divestment of Sites to NextPharma
Lonza exits both softgels and liquid-filled hard capsules and NextPharma plans to broaden its technology offering into lipid based finished dosage forms.Kristin Brooks 04.01.21
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
APIs | Breaking News | cGMP Manufacture | Industry News
Piramal Pharma to Acquire Indian API Manufacturer Hemmo
Adds peptide API development and manufacturing capabilities for growing number of oncology and metabolic therapies.Kristin Brooks 04.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Facilities | Industry News
Chime Biologics Expands CDMO Capabilities
Completes $190 million financing round to accelerate capacity expansion.Tim Wright, Editor, Contract Pharma 03.29.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity
Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.Tim Wright, Editor, Contract Pharma 03.25.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Takeda Enter Multi-RNA Target Alliance
To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.Kristin Brooks 03.22.21
-
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership
Enter license agreement for the development of iPSC-derived cell therapies.Tim Wright, Editor, Contract Pharma 03.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Maravai Expands CDMO Capabilities Through TriLink Biotechnologies
Offers end-to-end mRNA production with the launch of TriLink's plasmid DNA manufacturing services.Tim Wright, Editor, Contract Pharma 03.15.21
-
Breaking News | Capsules | Industry News
CapsCanada Launches Liquid-Filled Hard Capsule Mfg. Service in North America
New service aims to return pharmaceutical and OTC drug manufacturing back to North America.Kristin Brooks 03.10.21
-
Breaking News | cGMP Manufacture | Industry News
Altasciences Doubles Size of PA CDMO Facility
The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.Kristin Brooks 03.10.21
-
Bio News | Breaking News | Industry News
NMPA Accepts Application for Clinical Trial of Bifunctional Fusion Protein
JS201, developed by Junshi Biosciences, can simultaneously target PD-1 and TGF-β.Charles Sternberg, Assistant Editor 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
Baxter Biopharma Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine
Manufacturing to take place at Baxter’s state-of-the-art Halle/Westfalen, Germany facility.Tim Wright, Editor, Contract Pharma 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
Continues to build integrated capabilities platform for cell and gene therapy.Tim Wright, Editor, Contract Pharma 03.05.21
-
Combination Products & The CDMO Webinar - Watch Now On-Demand
During this webinar, regulatory and quality experts from Alcami provided insights into combination products and the latest regulatory guidance.
-
Solid Dosage/Creams/Ointments
Solid Dose Market Trends
A Q&A with Mark DaFonseca, chief business officer at CoreRx.Tim Wright, Editor, Contract Pharma 02.26.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Catalent Acquires Delphi Genetics
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.Tim Wright, Editor, Contract Pharma 02.23.21
-
Breaking News | Collaborations & Alliances
NovalGen and Halix Enter Strategic Partnership
Halix will provide manufacturing of clinical supply of NovalGen’s therapies.Charles Sternberg, Assistant Editor 02.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Century Therapeutics Significantly Expands Capabilities
Unveils new operational, laboratory and manufacturing facilities in Pennsylvania and New Jersey.Tim Wright, Editor, Contract Pharma 02.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Charles River Acquires CDMO Cognate BioServices
Pays roughly $875 million to significantly expand capabilities in the cell and gene therapy sector.Tim Wright, Editor, Contract Pharma 02.17.21
-
APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Lonza Expands Solid Small Molecule Services
To encompass all aspects of solid form screening and characterization of small molecule APIs.Kristin Brooks 02.16.21
-
Breaking News | Facilities | Industry News
Masy BioServices Expands Green Initiative
Completes a solar array project, installing 585 kW carports at its headquarters.Charles Sternberg, Assistant Editor 02.08.21
-
Breaking News | Industry News
TCG Lifesciences Expands Footprint to the U.S.
Establishes CDMO subsidiary TCG GreenChem in New Jersey and Virginia.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Paragon Biosciences Expands Cell and Gene Therapy Platform
Launches CiRC Biosciences with an initial focus on developing eye disease treatments.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Trizell Enter Cell Therapy Deal
Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.Tim Wright, Editor, Contract Pharma 02.08.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
Abzena will work with Immunome to produce the antibody cocktail for clinical testing.Kristin Brooks 02.03.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CureVac, Rentschler Ramp up COVID Vax Production
Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.Kristin Brooks 02.01.21
-
Parenterals
Parenteral Drug Delivery Trends
A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.Kristin Brooks, Managing Editor, Contract Pharma 01.27.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News | Laboratory Testing
Almac Expands Global Biologics Testing Services
Investment in mass spectrometry support aims to accelerate biologics development and approval.Tim Wright, Editor, Contract Pharma 01.27.21
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
X-Chem Acquires IntelliSyn and AviSyn
Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.Kristin Brooks 01.26.21
-
Breaking News | Capsules | Cold Chain Management | Fill/Finish | Industry News | Solid Dosage/Semi-solids
Aphena’s $21M Cookeville Expansion Nears Completion
Bottle packaging capacity has been expanded with the installation of 10 high-speed bottling lines to start.Kristin Brooks 01.26.21
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
Will produce sterile injectable meds used in hospitals for COVID-19 patient care.Tim Wright, Editor, Contract Pharma 01.25.21
-
Analytical Services | Laboratory Testing
Improving Product Profitability
Using PAT/QbD/CM as tools to increase profitability of products.Emil Ciurczak, Contributing Editor 01.21.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
Enter an agreement for a process development partnership.Contract Pharma Staff 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Intravacc Completes Project for Provention Bio’s Vax Candidate
Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.Contract Pharma Staff 01.19.21
-
APIs | Breaking News | Facilities | Industry News
Sanofi Unveils EUROAPI as Name of New European API Company
Appoints Karl Rotthier as its future Chief Executive Officer.Contract Pharma Staff 01.15.21
-
APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE Expands Fill Finish and Lyophilization Ops
New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.Contract Pharma Staff 01.14.21
-
Clinical Development
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.Contract Pharma Staff 01.13.21
-
How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective
Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Parenterals
Baxter, Novavax Ink Sterile Manufacturing Agreement
CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.Contract Pharma Staff 01.11.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Cyclolab and EpiPharma Form Joint Venture
Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.Contract Pharma Staff 01.11.21
-
-
Oligonucleotides
Syngene's services encompass Therapeutic oligonucleotides, Diagnostic Oligonucleotides, Enzymatic synthesis and analytical services.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Genezen Laboratories Receives Growth Equity Investment
Will fund the completion of the company’s lentiviral vector production facility.Contract Pharma Staff 01.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Will manufacture second-generation COVID-19 vaccine, AKS-452.Contract Pharma Staff 01.05.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $40M in New Facility
State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.Contract Pharma Staff 01.05.21
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.Contract Pharma Staff 12.17.20
-
APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Aurinia and Lonza Expand Manufacturing Partnership
Form agreement for voclosporin manufacturing capacity.Contract Pharma Staff 12.16.20
-
Breaking News | Industry News
AstraZeneca to Acquire Alexion in $39B Deal
Expands scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline, and top seller Soliris.Contract Pharma Staff 12.14.20
-
Breaking News | cGMP Manufacture | Industry News
Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies
Completion of dedicated cGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS product candidates.Contract Pharma Staff 12.10.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Parenterals
Thermo Fisher Scientific Further Expands Global Footprint
Will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy for sterile drug product development and commercial manufacturing.Contract Pharma Staff 12.10.20
-
APIs | Breaking News | Clinical Trial Materials | Facilities | Industry News
Recipharm Expands API Manufacturing Capabilities
Invests $2.5 million in clinical GMP capacity for APIs at Israel facility.Contract Pharma Staff 12.09.20
-
Breaking News | Promotions & Moves
Natoli Engineering Appoints West Coast Service Tech
Gerardo Zuniga brings 20 plus years of experience leveraging problem-solving techniques to implement corrective and preventative actions.Contract Pharma Staff 12.08.20
-
Breaking News | cGMP Manufacture | Industry News
HALIX, AstraZeneca Ink Commercial COVID-19 Vax Mfg. Pact
HALIX to provide large-scale GMP manufacture of AZD1222 at its cGMP facility in the Netherlands.Contract Pharma Staff 12.08.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Injectables | Parenterals
BD to Invest $1.2B in Pre-Fillable Syringe Manufacturing Capacity
Will roll-out over the next four years and includes a new manufacturing facility in Europe.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Cytovance Expands Partnership with Nature Technology Corp.
Now offers NTC’s proprietary HyperGRO manufacturing platform for plasmid DNA CGMP manufacturing.Contract Pharma Staff 12.03.20
-
Breaking News | Drug Development
ViGeneron and WuXi Advanced Therapies Enter Partnership
Will accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.Contract Pharma Staff 12.02.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
KBI Biopharma Expands U.S. Ops
Invests $150 million in commercial biologics manufacturing facility in RTP, NC.Contract Pharma Staff 12.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
CDMO Stelis Continues Expansion
Starts next phase of investment into its biologics manufacturing facility.Contract Pharma Staff 12.01.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
APIs | Breaking News | Facilities | Industry News
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.Contract Pharma Staff 11.25.20
-
Breaking News | Facilities | Industry News
Abenza Upgrades Chemistry GMP Suites
Appoints new leadership at Bristol PA site.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | cGMP Manufacture | Facilities | Fill/Finish | Industry News
August Bioservices Expands Operations in Nashville
Plans to invest $64.7 million and create 180 jobs over the next five years.Contract Pharma Staff 11.20.20
-
Breaking News | Facilities | Industry News
CordenPharma Expands Peptide Development Capacity
Increases CoE for peptide development capacity to support European domestic growth.Contract Pharma Staff 11.18.20
-
A Potential “Marriage”
Initiator companies and generics/CMOs working together.Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
-
Scale-up/Technology Transfer
Ensuring Quality During the Transfer and Scale Up of Rx Drugs
Defining the key parameters and considerations for a successful technology transfer.Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20
-
Breaking News | Collaborations & Alliances | Industry News
Lead Pharma and Roche Enter Collaboration & License Agreement
Will develop oral small molecules to treat immune mediated diseases.Contract Pharma Staff 11.16.20
-
Breaking News | Collaborations & Alliances | CRO News
PathoQuest, Charles River Expand Strategic Pact
Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.Contract Pharma Staff 11.12.20
-
Breaking News | Collaborations & Alliances | Industry News
AzurRx BioPharma Partners with Asymchem
Will develop and produce MS1819 for the treatment of exocrine pancreatic insufficiency.Contract Pharma Staff 11.12.20
-
Bio News | Breaking News | Facilities | Industry News
Stelis BioSource Continues Facility Investment
Will install two 2,000L single-use bioreactor trains in its mammalian CGMP facility.Contract Pharma Staff 11.12.20
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
CDMOs: Keeping up with Science & Technology
Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.Kristin Brooks, Contract Pharma 11.12.20
-
Breaking News | Industry News
TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity
Strategic partnership will leverage technical capabilities at ElevateBio for the production of TC-210 to support Phase II clinical trial.Contract Pharma Staff 11.11.20
-
Aseptic Processing | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Argonaut Manufacturing Services Completes First cGMP Run
New automated aseptic fill/finish line for clinical and commercial use was recently approved by regulators.Contract Pharma Staff 11.06.20
-
Breaking News | CRO News | Industry News
ACG Acquires Significant Stake in IQGEN-X
Enables IQGEN-X to fast-track research on existing ANDAs and set up another cGMP pilot facility.Contract Pharma Staff 11.05.20
-
Breaking News | Facilities | Industry News
Seqens Unveils Innovation and Development CoE
SEQENS'Lab is a development accelerator located just out of Paris06.20.19
-
Breaking News | Industry News
Major News Impacting the Pharma Mfg. Value Chain
DCAT Member Company Announcement Forum is an exclusive venue for DCAT member companies to present announcements on major news02.25.19
-
Bio News | Breaking News | Industry News
PCI Synthesis to Become SEQENs
The name change comes six months after PCI Synthesis was acquired by Novacap12.19.18
-
APIs | Breaking News | Industry News | Process Development
-
APIs | Breaking News | cGMP Manufacture | Industry News
Predictions for the Generic Drug Sector in 2018
PCI Synthesis shares expected trends in the industry within the next year
-
Industry News | Promotions & Moves
PCI Synthesis Hires New Business Development Manager
The new addition has over twenty years of industry experience, and will be based out of California11.15.17
-
Aseptic Processing | Fill/Finish | Parenterals
Aseptic Fill-Finish Trends
Catalent’s Carole Delauney discusses aseptic fill-finish market trends, challenges and growth opportunities.Tim Wright, Editor, Contract Pharma 01.05.17
-
APIs | Breaking News | cGMP Manufacture | Facilities | GMPs/GCPs | Industry News | Validation
PCI Synthesis Obtains DEA Registration for Controlled Substance Dev't and Mnf’g
Expands capabilities to handle cGMP development for schedule II, III, IV and V09.15.16
-
APIs | Breaking News | cGMP Manufacture | Drug Development | Industry News
PCI Synthesis Adds Advanced Polymer Mfg. Group
New capability expands customer base and reach within this market04.20.16
-
Analytical Services | APIs | Clinical Trials | Promotions & Moves
-
Analytical Services | Promotions & Moves
Averica Appoints Cynthia Berger VP of Operations
Previously worked as project manager at PCI Synthesis01.21.16
-
APIs | Breaking News | Capsules | cGMP Manufacture | Excipients | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
PCI Partners With a Dozen Local Biotech Customers
Deepens connections with the greater Boston life sciences community06.10.15
-
APIs | Inspections | Supply Chain
Notes From DCAT Week ’15
Program objectives and challenges for the FDA’s Quality Metrics InitiativeKristin Brooks, Contract Pharma 03.25.15
-
APIs | Chemistry | Inspections | Supply Chain
API Sourcing Trends
Ed Price of PCI Synthesis addresses trends, regulatory and supply chain hurdles, and quality concernsKristin Brooks, Contract Pharma 03.19.15
-
Breaking News | Process Development | Promotions & Moves
Cedarburg Hauser Appoints Process Development Director
Tretyakov to lead process and analytical development groupsKristin Brooks 02.11.14
-
APIs | Breaking News | Chemistry | Custom Sourcing News | Promotions & Moves
-
APIs | Breaking News | Custom Sourcing News | GMPs/GCPs | Inspections | Regulatory Affairs
-
Breaking News | Promotions & Moves | R&D
